Back to top

Image: Bigstock

Top Ranked Momentum Stocks to Buy for January 30th

Read MoreHide Full Article

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 30th:

AC Immune SA (ACIU - Free Report) : This clinical stage biopharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 66.7% over the last 60 days.

AC Immune SA Price and Consensus

AC Immune's shares gained 8.3% over the last one month compared to S&P 500’s rise of 1.6%. The company possesses a Momentum Score of A.

AC Immune SA Price

Agilysys, Inc. (AGYS - Free Report) : This developer and marketer of hardware and software products and services to the hospitality industry has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 50% over the last 60 days.

Agilysys, Inc. Price and Consensus

Agilysys’ shares gained 30% over the last one month. The company possesses a Momentum Score of B.

Agilysys, Inc. Price

American Express Company (AXP - Free Report) : This provider of charge and credit payment card products as well as travel-related services has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.7% over the last 60 days.

American Express Company Price and Consensus

American Express’ shares gained 4.1% over the last one month. The company possesses a Momentum Score of A.

American Express Company Price

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


American Express Company (AXP) - free report >>

Agilysys, Inc. (AGYS) - free report >>

AC Immune SA (ACIU) - free report >>

Published in